MA69005B1 - Compositions et procédés pour la stabilisation de micro-arn - Google Patents

Compositions et procédés pour la stabilisation de micro-arn

Info

Publication number
MA69005B1
MA69005B1 MA69005A MA69005A MA69005B1 MA 69005 B1 MA69005 B1 MA 69005B1 MA 69005 A MA69005 A MA 69005A MA 69005 A MA69005 A MA 69005A MA 69005 B1 MA69005 B1 MA 69005B1
Authority
MA
Morocco
Prior art keywords
microrna
compositions
stabilizing
methods
micrornas
Prior art date
Application number
MA69005A
Other languages
English (en)
Inventor
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Publication of MA69005B1 publication Critical patent/MA69005B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/30—Characterised by physical treatment
    • C12Q2523/31—Electrostatic interactions, e.g. use of cationic polymers in hybridisation reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/207—Modifications characterised by siRNA, miRNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/125—Specific component of sample, medium or buffer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/143—Concentration of primer or probe
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/107—Reactions characterised by their quantitative nature the purpose being quantitative analysis with a competitive internal standard/control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)

Abstract

La présente invention concerne la stabilisation de molécules de micro-ARN. Les compositions et méthodes décrites ici peuvent être avantageusement utilisées pour la fourniture de microARN de contrôle interne et standard destinés à être inclus dans des kits, utiles pour la quantification normalisée, relative ou absolue d'un microARN dans un fluide biologique.
MA69005A 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn MA69005B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305496 2019-04-16
EP23164521.9A EP4223886B1 (fr) 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn

Publications (1)

Publication Number Publication Date
MA69005B1 true MA69005B1 (fr) 2025-01-31

Family

ID=66334331

Family Applications (1)

Application Number Title Priority Date Filing Date
MA69005A MA69005B1 (fr) 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn

Country Status (18)

Country Link
US (1) US20220186313A1 (fr)
EP (2) EP3956470A1 (fr)
JP (2) JP2022529035A (fr)
KR (1) KR20210153077A (fr)
CN (1) CN113661251B (fr)
AU (1) AU2020259847B2 (fr)
DK (1) DK4223886T3 (fr)
EA (1) EA202192832A1 (fr)
ES (1) ES3005085T3 (fr)
FI (1) FI4223886T3 (fr)
IL (1) IL286580B2 (fr)
MA (1) MA69005B1 (fr)
MX (1) MX2021012610A (fr)
PL (1) PL4223886T3 (fr)
PT (1) PT4223886T (fr)
TW (1) TWI866964B (fr)
WO (1) WO2020212522A1 (fr)
ZA (1) ZA202109058B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113677336B (zh) 2019-04-10 2024-04-30 基恩菲特公司 包含式(i)化合物和glp-1受体激动剂的组合疗法
GB2594317B (en) * 2020-04-23 2022-05-25 Univ Johannesburg Witwatersrand SARS-CoV-2 Diagnostic control compositions
US20220340962A1 (en) * 2021-04-22 2022-10-27 Genfit Quantitative detection of micro-rnas
CN115737557B (zh) * 2022-11-18 2024-04-09 黑龙江中医药大学 一种miR-55制剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
EP0702516A4 (fr) 1993-06-01 1998-04-22 Life Technologies Inc Immunisation genetique a l'aide de lipides cationiques
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5674908A (en) 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
EP0874910A4 (fr) 1995-06-07 1999-04-21 Life Technologies Inc Transfection par lipides cationiques amelioree par des peptides
US20030069173A1 (en) 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
EP1829856A3 (fr) 1998-11-12 2009-02-25 Invitrogen Corporation Réactifs de transfection
WO2002034879A2 (fr) 2000-10-27 2002-05-02 Invitrogen Corporation Procede d'introduction d'oligonucleotides antisens dans des cellules eucaryotes
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US7404969B2 (en) * 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
US20060228406A1 (en) 2005-03-17 2006-10-12 Invitrogen Corporation Transfection reagent for non-adherent suspension cells
WO2011110644A1 (fr) * 2010-03-11 2011-09-15 National University Of Ireland, Galway Détection et quantification de microarn dans la circulation et utilisation de microarn circulants en tant que biomarqueurs pour le cancer
JP2014508102A (ja) 2010-11-15 2014-04-03 ライフ テクノロジーズ コーポレーション アミン含有トランスフェクション試薬ならびにそれを生成および使用するための方法
CN103205483B (zh) * 2012-01-13 2017-02-08 北京命码生科科技有限公司 microRNA标准化的内参基因及其用途
WO2013148151A1 (fr) * 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Acides microribonucléiques plasmatiques à titre de biomarqueurs de l'endométriose et du cancer de l'ovaire associé à l'endométriose (eaoc)
US20150080229A1 (en) * 2012-03-29 2015-03-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
WO2016011203A1 (fr) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions comprenant des agrégats lipidiques et procédés d'administration efficace de molécules dans des cellules
JP2018523696A (ja) * 2015-08-20 2018-08-23 アソシアシオン・セントロ・デ・インベスティガシオン・コオペラティバ・エン・ビオシエンシアス−セイセ ビオグネ 肝疾患および状態を治療する方法および組成物
JP2017093377A (ja) * 2015-11-26 2017-06-01 国立大学法人 東京医科歯科大学 肝がんモデルマウスおよび肝がん治療用の医薬
EA201892201A1 (ru) * 2016-03-30 2019-03-29 Женфит Неинвазивная диагностика неалкогольного стеатогепатита
CA3073851A1 (fr) 2017-08-31 2019-03-07 Life Technologies Corporation Compositions lipidiques cationiques pour administration specifique a un tissu

Also Published As

Publication number Publication date
WO2020212522A1 (fr) 2020-10-22
EP4223886A3 (fr) 2023-09-13
EP4223886B1 (fr) 2024-10-02
ZA202109058B (en) 2025-05-28
EP3956470A1 (fr) 2022-02-23
AU2020259847B2 (en) 2024-09-19
PL4223886T3 (pl) 2025-03-31
AU2020259847A1 (en) 2021-11-04
TW202104599A (zh) 2021-02-01
TWI866964B (zh) 2024-12-21
PT4223886T (pt) 2024-12-20
CN113661251B (zh) 2024-08-23
DK4223886T3 (da) 2025-01-02
JP2025067916A (ja) 2025-04-24
ES3005085T3 (en) 2025-03-13
JP2022529035A (ja) 2022-06-16
IL286580A (en) 2021-10-31
US20220186313A1 (en) 2022-06-16
CN113661251A (zh) 2021-11-16
EA202192832A1 (ru) 2022-01-19
KR20210153077A (ko) 2021-12-16
FI4223886T3 (fi) 2024-12-27
BR112021020664A2 (pt) 2021-12-07
CA3130522A1 (fr) 2020-10-22
IL286580B2 (en) 2025-01-01
MX2021012610A (es) 2021-11-12
EP4223886A2 (fr) 2023-08-09
IL286580B1 (en) 2024-09-01

Similar Documents

Publication Publication Date Title
MA30394B1 (fr) Synthese d'acylaminoalcenylene-amides pouvant etre employes en tant qu'antagonistes de la substance p
MX2025010403A (es) Moleculas que tienen ciertas utilidades plaguicidas e intermedios, composiciones y procesos relacionados con ellas
MA52746B1 (fr) Molécules à utilité pesticide, compositions et procédés associés
MX2023000289A (es) Moleculas que tienen utilidad plaguicida, e intermediarios, composiciones, y procesos, relacionados a las mismas.
MA31763B1 (fr) Inhibiteurs de kinase de type polo
MA31151B1 (fr) Inhibiteurs de mapk/erk kinase
MA32615B1 (fr) Inhibiteurs de cmet
MA29746B1 (fr) Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l'hepatite c
MX2018008846A (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos relacionados con ellas.
UY31633A1 (es) Plaguicidas mesoiónicos
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
MA31683B1 (fr) Composes et procedes pour moduler fxr
WO2013101974A8 (fr) Composés de traitement d'une amyotrophie spinale
GT201200316A (es) Forma cristalina de 4- [5-[3-cloro-5-(trifluorometil) fenil]-4,5-dihidro-5-(trifluorometil)-3-isoxazolil-n-[2-0x0-2- [(2,2,-trifluoroetil) amino] etil]-1-naftalenocarboxamida
MA33653B1 (fr) Couche colorée amovible pour revêtements d'ongles artificiels et procédés pour celle-ci
TW201613879A (en) Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
FR3030261B1 (fr) Composition comprenant des particules de polymere stabilise et un polymere filmogene hydrophobe
ATE531769T1 (de) Verwendung von estern als koaleszenzmittel
MA38403A1 (fr) Nouveaux dérivés de pyrazole modulateurs specifiques de cb2
EP1740559A4 (fr) Derives de phenyle 1,3,5-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
FR3099058B1 (fr) Utilisation d'un dérivé de glycine bétaïne comme agent de conditionnement des cheveux
MA38240A1 (fr) Nouveaux composes dimeres substitues antagonistes de l'iap utiles pour le traitement du cancer, de preference des tumeurs solides
ZA202109058B (en) Compositions and methods for the stabilization of micro-rna
BRPI0601434A (pt) dispersões de poliuretano com propriedades de formação de pelìcula aperfeiçoadas